Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

November
14
2022

Dr. Mark Nestor to Receive Presidential Citation from American Academy of Dermatology

The American Academy of Dermatology will honor Sensus Medical Advisor, Dr. Mark S. Nestor, MD, PhD, FAAD with the American Academy of Dermatology’s Presidential Citation, in recognition of his dedication and leadership in the field…

November
03
2022

Sensus Healthcare Reports Third Quarter 2022 Financial Results

Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 03, 2022 —…

October
27
2022

Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022

BOCA RATON, Fla., Oct. 27, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

October
20
2022

Sensus Healthcare Introduces Silk™ Laser Hair Removal System

Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology Conference BOCA RATON, Fla, Oct. 20, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy